Your browser doesn't support javascript.
loading
Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting.
Kejík, Zdenek; Koubková, Nela; Krcová, Lucie; Sýkora, David; Abramenko, Nikita; Veselá, Katerina; Kaplánek, Robert; Hajduch, Jan; Houdová Megová, Magdalena; Busek, Petr; Sedo, Aleksi; Lacina, Lukás; Smetana, Karel; Martásek, Pavel; Jakubek, Milan.
Afiliación
  • Kejík Z; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Pragu
  • Koubková N; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, Technická 6, 166 28 Prague, Czech Repu
  • Krcová L; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Pragu
  • Sýkora D; Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, Technická 6, 166 28 Prague, Czech Republic.
  • Abramenko N; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Pragu
  • Veselá K; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Pragu
  • Kaplánek R; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Chemistry of Natural Compounds, Faculty of Food and Biochemical Technology, University of Chemistry and Technology, Technická 6, 166
  • Hajduch J; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Chemistry of Natural Compounds, Faculty of Food and Biochemical Technology, University of Chemistry and Technology, Technická 6, 166
  • Houdová Megová M; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, CZ-120 00 Prague, Czech Republic.
  • Busek P; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, CZ-120 00 Prague, Czech Republic.
  • Sedo A; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, CZ-120 00 Prague, Czech Republic.
  • Lacina L; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Dermatovenerology, First Faculty of Medicine, Charles University and General University Hospital, CZ-128 08 Prague, Czech Republic; I
  • Smetana K; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Prumyslová 595, 252 50 Vestec, Czech Republic; Institute of Anatomy, First Faculty of Medicine, Charles University, Prague 2, CZ-120 00 Prague, Czech Republic.
  • Martásek P; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic.
  • Jakubek M; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Pragu
Bioorg Chem ; 141: 106816, 2023 12.
Article en En | MEDLINE | ID: mdl-37716274
ABSTRACT
Pentamethinium indolium salts are promising fluorescence probes and anticancer agents with high mitochondrial selectivity. We synthesized two indolium pentamethinium salts a cyclic form with quinoxaline directly incorporated in the pentamethinium chain (cPMS) and an open form with quinoxaline substitution in the γ-position (oPMS). To better understand their properties, we studied their interaction with mitochondrial phospholipids (cardiolipin and phosphatidylcholine) by spectroscopic methods (UV-Vis, fluorescence, and NMR spectroscopy). Both compounds displayed significant affinity for cardiolipin and phosphatidylcholine, which was associated with a strong change in their UV-Vis spectra. Nevertheless, we surprisingly observed that fluorescence properties of cPMS changed in complex with both cardiolipin and phosphatidylcholine, whereas those of oPMS only changed in complex with cardiolipin. Both salts, especially cPMS, display high usability in mitochondrial imaging and are cytotoxic for cancer cells. The above clearly indicates that conjugates of pentamethinium and quinoxaline group, especially cPMS, represent promising structural motifs for designing mitochondrial-specific agents.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cardiolipinas / Antineoplásicos Idioma: En Revista: Bioorg Chem Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cardiolipinas / Antineoplásicos Idioma: En Revista: Bioorg Chem Año: 2023 Tipo del documento: Article